Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, The Netherlands.
Department of Anesthesiology, University Medical Center Groningen, University of Groningen, The Netherlands.
Ann Thorac Surg. 2018 Jul;106(1):92-98. doi: 10.1016/j.athoracsur.2018.01.066. Epub 2018 Mar 1.
Perioperative acute kidney injury (AKI) is an important predictor of long-term all-cause mortality after coronary artery bypass (CABG). However, the effect of AKI on long-term mortality after cardiac valve operations is hitherto undocumented.
Perioperative renal injury and long-term all-cause mortality after valve operations were studied in a prospective cohort of patients undergoing solitary valve operations (n = 2,806) or valve operations combined with CABG (n = 1,260) with up to 18 years of follow-up. Postoperative serum creatinine increase was classified according to AKI staging 0 to 3. Patients undergoing solitary CABG (n = 4,938) with cardiopulmonary bypass served as reference.
In both valve and valve+CABG operations, postoperative renal injury of AKI stage 1 or higher was progressively associated with an increase in long-term mortality (hazard ratio [HR], 2.27, p < 0.05 for valve; HR, 1.65, p < 0.05 for valve+CABG; HR, 1.56, p < 0.05 for CABG). Notably, the mortality risk increased already substantially at serum creatinine increases of 10% to 25%-that is, far below the threshold for AKI stage 1 after valve operations (HR, 1.39, p < 0.05), but not after valve operations combined with CABG or CABG only.
An increase in serum creatinine by more than 10% during the first week after valve operation is associated with an increased risk for long-term mortality after cardiac valve operation. Thus, AKI classification clearly underestimates long-term mortality risk in patients undergoing valve operations.
围手术期急性肾损伤(AKI)是冠状动脉旁路移植术(CABG)后全因死亡的重要预测因素。然而,AKI 对心脏瓣膜手术后长期死亡率的影响迄今尚未记录。
前瞻性队列研究了 2806 例单纯瓣膜手术或瓣膜手术联合 CABG(n=1260)患者的围手术期肾损伤和瓣膜手术后长期全因死亡率,随访时间长达 18 年。根据 AKI 分期 0 至 3 对术后血清肌酐升高进行分类。接受体外循环单纯 CABG(n=4938)的患者作为参考。
在瓣膜和瓣膜+CABG 手术中,AKI 分期 1 或更高的术后肾脏损伤与长期死亡率的增加呈正相关(瓣膜手术的危险比[HR],2.27,p<0.05;瓣膜+CABG 手术的 HR,1.65,p<0.05;CABG 手术的 HR,1.56,p<0.05)。值得注意的是,即使在瓣膜手术后 AKI 分期 1 的阈值以下,即血清肌酐升高 10%至 25%时,死亡率风险已经显著增加(HR,1.39,p<0.05),但在瓣膜手术后联合 CABG 或单纯 CABG 手术中并非如此。
瓣膜手术后第一周内血清肌酐增加超过 10%与心脏瓣膜手术后长期死亡率增加相关。因此,AKI 分类明显低估了接受瓣膜手术患者的长期死亡率风险。